These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde. Lima VA; do Nascimento LA; Eliezer D; Follmer C ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158 [TBL] [Abstract][Full Text] [Related]
9. Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease. Kilpeläinen T; Julku UH; Svarcbahs R; Myöhänen TT Sci Rep; 2019 Nov; 9(1):17382. PubMed ID: 31758049 [TBL] [Abstract][Full Text] [Related]
10. Inducible Alpha-Synuclein Expression Affects Human Neural Stem Cells' Behavior. Zasso J; Ahmed M; Cutarelli A; Conti L Stem Cells Dev; 2018 Jul; 27(14):985-994. PubMed ID: 29669468 [TBL] [Abstract][Full Text] [Related]
11. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity. Vinueza-Gavilanes R; Íñigo-Marco I; Larrea L; Lasa M; Carte B; Santamaría E; Fernández-Irigoyen J; Bugallo R; Aragón T; Aldabe R; Arrasate M Neurobiol Dis; 2020 Apr; 137():104781. PubMed ID: 31991248 [TBL] [Abstract][Full Text] [Related]
12. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease. Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158 [TBL] [Abstract][Full Text] [Related]
13. Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity. Ysselstein D; Joshi M; Mishra V; Griggs AM; Asiago JM; McCabe GP; Stanciu LA; Post CB; Rochet JC Neurobiol Dis; 2015 Jul; 79():150-63. PubMed ID: 25931201 [TBL] [Abstract][Full Text] [Related]
14. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040 [TBL] [Abstract][Full Text] [Related]
15. Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson's Patient-Derived Neuronal Cells. Seebauer L; Schneider Y; Drobny A; Plötz S; Koudelka T; Tholey A; Prots I; Winner B; Zunke F; Winkler J; Xiang W Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163733 [TBL] [Abstract][Full Text] [Related]
16. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains. Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665 [TBL] [Abstract][Full Text] [Related]
17. Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death. Vekrellis K; Xilouri M; Emmanouilidou E; Stefanis L J Neurochem; 2009 Jun; 109(5):1348-62. PubMed ID: 19476547 [TBL] [Abstract][Full Text] [Related]
18. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756 [TBL] [Abstract][Full Text] [Related]
19. Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation. Pieger K; Schmitt V; Gauer C; Gießl N; Prots I; Winner B; Winkler J; Brandstätter JH; Xiang W Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009004 [TBL] [Abstract][Full Text] [Related]
20. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. Vogiatzi T; Xilouri M; Vekrellis K; Stefanis L J Biol Chem; 2008 Aug; 283(35):23542-56. PubMed ID: 18566453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]